Contact
searchSearch
HMP Global
Sponsored Video

Evidence Supporting Treatment in Challenging AAA Anatomy: Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Clinical Trial Data

Gustavo S. Oderich, MD
Robert Rhee, MD
Sukgu Han, MD
07/01/2026

Experts review pivotal trial design and outcomes, sharing clinical perspectives on treating short and highly angulated neck anatomies with the GORE® EXCLUDER® Conformable device.

Related Content

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Interview
Confronting the Gender Gap in AAA Care: Women Face Worse Outcomes and What Needs to Change
02/18/2026
Jon Matsumura, MD
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA...
02/18/2026
Vascular Disease Management
John S. Pellerito, MD
ISET 2026
CEUS in Vascular Imaging—EVAR Follow-Up and Beyond
02/09/2026
John S. Pellerito, MD
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Flow Visualization
The University of Turin Adopts Openwater’s Open-Motion Device to Study Muscle Blood Flow and Vascular Responses
09/29/2026
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
Open-Motion uses near-infrared...
09/29/2026
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola Coronary Laser IVL System
09/29/2026
A 30-patient feasibility study demonstrated calcium fracture in every treated lesion and 49% acute lumen gain prior to stenting.
A 30-patient feasibility study demonstrated calcium fracture in every treated lesion and 49% acute lumen gain prior to stenting.
A 30-patient feasibility study...
09/29/2026
Cath Lab Digest
Pulmonary Arterial Hypertension (PAH)
FDA Updates Winrevair Label With HYPERION Data in Newly Diagnosed PAH
09/23/2026
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling...
09/23/2026
Cath Lab Digest
Hand Protection
Mölnlycke Launches Biogel Radiation Protection Gloves to Tackle Low Adoption of Hand Protection in Radiation-Guided Surgical Procedures
09/22/2026
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC....
09/22/2026
Cath Lab Digest
TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Pulmonary Embolism
PRAGUE-26 Trial: Evaluating Catheter-Directed Thrombolysis for Intermediate-High Risk Pulmonary Embolism Patients Versus Standard Anticoagulation Therapy Alone
09/01/2026
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial...
09/01/2026
Cath Lab Digest
NYU Langone
NYU Langone Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
08/27/2026
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed...
08/27/2026
Vascular Disease Management
Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use